Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In
  • Become a Member Org.
  • MB Vision
  • Members
    • Become a Member
    • Benefits
      • Savings and Rewards
    • Member News
    • Member Events
    • Directory
    • Career Center
    • FAQs
    • Pay Company Dues
  • Events
    • Upcoming
    • Event Descriptions
    • Sponsorship Opportunities
    • Member Events
  • Innovation
    • About
    • MassBioDrive
      • Application
      • Alumni
      • Get Involved
      • Partners
      • FAQs
    • Partnering
  • Savings
    • MassBioEdge
  • Conference Center
    • About MassBioHub
    • Reserve Today
  • Policy & Advocacy
    • Policy & Advocacy Efforts
    • Diversity, Equity, and Inclusion
    • Economic Development
      • BioReady Communities
    • Workforce Development
      • Bioversity
    • Industry Reports
      • Industry Snapshot
      • Biopharma Funding Report
      • DEI Report
      • MA Life Sciences Workforce
  • About
    • About MassBio
    • MB Vision
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board
    • Career Center
    • Contact Us
  • Sign In
  • Become a Member Org.
  • MB Vision
Open search form

Member News

Click to Open Main Menu
News

Ultragenyx Finalizes Phase 3 Study Design for DTX301 (OTC) with FDA

Apr 22, 2021

Posted by Ultragenyx

See all Member News

Share

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • News & Thought Leadership
  • Pay Company Dues
  • Join Today
  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2024 All Rights Reserved